TRex Bio, Inc. (TRXB)

TRex Bio will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

TRex Bio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0	-	39.11
Revenue Growth	-	-	-
Gross Profit	0	-	39.11
Operating Income	-49.64	-37.85	-2.38
Net Income	-46.39	-34.81	-8.89

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	90.85	67.73	65.31
Total Debt	0.2	0.72	0.7
Net Cash (Debt)	90.66	67.01	64.61
Net Cash Growth	-	3.71%	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-46.25	-41.36	-25.58
Capital Expenditures	-0.06	-0.07	-0.07
Free Cash Flow	-46.31	-41.43	-25.65
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	-	-	100.00%
Operating Margin	-	-	-6.09%
Pretax Margin	-	-	-15.83%
Profit Margin	-	-	-22.73%
FCF Margin	-	-	-65.59%